The dysregulation of MUM-146 in disease has sparked interest in its potential as a therapeutic target. Several studies have explored the use of MUM-146 inhibitors or mimics as a means to modulate its expression and treat disease.
MUM-146 is a member of the miR-146 family, which consists of two homologous miRNAs, miR-146a and miR-146b. These miRNAs have been shown to regulate gene expression by binding to the 3' untranslated region (UTR) of target mRNAs, leading to their degradation or translational inhibition. mum-146
MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression at the post-transcriptional level. MUM-146, a member of the miRNA family, has been gaining attention in recent years due to its involvement in various diseases and its potential as a therapeutic target. This review aims to summarize the current state of knowledge on MUM-146, including its function, mechanism of action, and roles in disease pathogenesis. The dysregulation of MUM-146 in disease has sparked
: It was produced by the studio Minimum and released in early 2015. These miRNAs have been shown to regulate gene
§ 144.102 Scope and applicability. * (a) For purposes of 45 CFR parts 144 through 149, all health insurance coverage is generally ... eCFR (.gov) 2 sites part 146—requirements for the group health insurance market § 146.101 Basis and scope. (a) Statutory basis. This part implements the Group Market requirements of the PHS Act. Its purpose is ... eCFR (.gov) part 144—requirements relating to health insurance coverage - eCFR Jul 13, 2021 —
MUM-146 is a microRNA with emerging roles in disease and therapy. Further research is needed to fully understand its function and mechanism of action, as well as its potential as a therapeutic target.